Adding Navitoclax to Ruxolitinib Doubles Spleen Volume Reductions for Myelofibrosis
MRD Positivity Correlates With Allogeneic Transplant Benefits in NPM1-Mutated AML
Orca-T Shows High Survival Rates in Intermediate-/High-Risk Myelodysplastic Syndrome
Orca-T Demonstrates Feasibility in Older Patients With Hematologic Malignancies